It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2018.
2018 | New Delhi, Delhi, India | ActiveGeniosporum Pharmaceuticals Private Limited, a active private limited company, was established on 24 February 2018 in New Delhi, Delhi, India. Engaging in medical & laboratory equipment within the hospital and medical care sector, it holds CIN: U74994DL2018PTC329947. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Amit Choudhary (Director), Ankesh Ranjan (Director), Saurav Suman (Director). Past directors included Ankesh Ranjan. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at H. No: 384, Ground Floor, Village Munirka, New Delhi, Delhi, 110067.
U74994DL2018PTC329947
329947
24 February 2018
₹1.00 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Geniosporum Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Choudhary | Director | 24 Feb 2018 | Current |
| Ankesh Ranjan | Director | 24 Feb 2018 | Current |
| Saurav Suman | Director | 24 Feb 2018 | Current |
| Amit Kumar | Director | 24 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Geniosporum Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 72.83% increase. The company also saw a substantial improvement in profitability, with a 101.59% increase in profit. The company's net worth moved up by a moderate rise of 1.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Geniosporum Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Geniosporum Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Geniosporum Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geniosporum Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Geniosporum Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
Progress on Geniosporum Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Delhi. was documented.
The activity Amit Choudhary was appointed as a Director was appointed as a Director on 24 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
The activity Ankesh Ranjan was appointed as a Director was appointed as a Director on 24 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
The activity Saurav Suman was appointed as a Director was appointed as a Director on 24 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
Progress on Amit Kumar was appointed as a Director was appointed as a Director on 24 Feb 2018 & has been associated with this company since 7 years 9 months . was documented.
The CIN of Geniosporum Pharmaceuticals Private Limited is U74994DL2018PTC329947.
Geniosporum Pharmaceuticals Private Limited is headquartered at H. No: 384, Ground Floor, Village Munirka, New Delhi, Delhi, 110067.
Geniosporum Pharmaceuticals Private Limited was incorporated on 24 February 2018.
The current directors of Geniosporum Pharmaceuticals Private Limited are
The primary industry of Geniosporum Pharmaceuticals Private Limited is Hospital And Medical Care.
Geniosporum Pharmaceuticals Private Limited is unlisted.
The authorized capital of Geniosporum Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX